IRIS UniCatt

Trecarichi, Enrico Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.059
NA - Nord America 4.289
AS - Asia 3.641
SA - Sud America 584
AF - Africa 68
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 8
Totale 13.658
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.165
DE - Germania 2.592
SG - Singapore 1.425
CN - Cina 1.332
SE - Svezia 545
BR - Brasile 451
IT - Italia 445
FR - Francia 341
UA - Ucraina 296
GB - Regno Unito 288
VN - Vietnam 240
IE - Irlanda 137
IN - India 112
BD - Bangladesh 103
TR - Turchia 96
FI - Finlandia 92
ID - Indonesia 88
PL - Polonia 85
RU - Federazione Russa 72
CA - Canada 58
AR - Argentina 55
HK - Hong Kong 43
JP - Giappone 40
MX - Messico 40
IQ - Iraq 30
NL - Olanda 30
BE - Belgio 25
EC - Ecuador 20
CO - Colombia 18
ES - Italia 16
VE - Venezuela 14
ZA - Sudafrica 14
PK - Pakistan 12
RO - Romania 12
SA - Arabia Saudita 12
AT - Austria 11
IR - Iran 11
IL - Israele 9
KR - Corea 9
AZ - Azerbaigian 8
CH - Svizzera 8
CI - Costa d'Avorio 8
JM - Giamaica 8
PH - Filippine 8
AU - Australia 7
JO - Giordania 7
KZ - Kazakistan 7
LT - Lituania 7
MA - Marocco 7
NP - Nepal 7
PE - Perù 7
UZ - Uzbekistan 7
BG - Bulgaria 6
CR - Costa Rica 6
CZ - Repubblica Ceca 6
DZ - Algeria 6
EG - Egitto 6
EU - Europa 6
KE - Kenya 6
AE - Emirati Arabi Uniti 5
BO - Bolivia 5
CL - Cile 5
HU - Ungheria 5
RS - Serbia 5
TN - Tunisia 5
UY - Uruguay 5
VA - Santa Sede (Città del Vaticano) 5
AL - Albania 4
ET - Etiopia 4
LV - Lettonia 4
MY - Malesia 4
PY - Paraguay 4
TW - Taiwan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BN - Brunei Darussalam 3
HR - Croazia 3
KG - Kirghizistan 3
MD - Moldavia 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
TH - Thailandia 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BZ - Belize 2
CM - Camerun 2
CY - Cipro 2
DJ - Gibuti 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GD - Grenada 2
GR - Grecia 2
GT - Guatemala 2
LA - Repubblica Popolare Democratica del Laos 2
ME - Montenegro 2
MU - Mauritius 2
NI - Nicaragua 2
OM - Oman 2
PT - Portogallo 2
AM - Armenia 1
AO - Angola 1
Totale 13.646
Salva come PNG Salva come JPEG
Città #
Singapore 788
Chandler 552
Ashburn 449
Hangzhou 441
San Jose 400
Jacksonville 205
Nürnberg 202
Beijing 201
San Mateo 153
Ann Arbor 144
Dublin 136
Nanjing 136
Dearborn 118
New York 115
Los Angeles 102
Jakarta 81
Wilmington 81
Izmir 75
Milan 75
Lauterbourg 74
Ho Chi Minh City 72
Hanoi 65
Munich 64
Woodbridge 63
The Dalles 62
Boston 60
Lawrence 56
Kraków 55
Marseille 55
Hefei 53
Moscow 53
Frankfurt am Main 52
Nanchang 52
Houston 50
Buffalo 45
Cattolica 45
Redwood City 45
Chicago 43
Rome 42
São Paulo 42
Seattle 39
Hong Kong 38
Bremen 37
Tokyo 33
Kunming 31
Dallas 30
Tianjin 29
Shenyang 27
Santa Clara 26
Brussels 25
Shanghai 23
Mountain View 22
Toronto 22
Brooklyn 21
Hebei 21
Helsinki 21
Princeton 21
Norwalk 20
Boardman 19
Orem 19
Changsha 18
Guangzhou 18
Warsaw 18
Leawood 17
Redmond 17
Lancaster 16
Fairfield 15
London 15
Mexico City 15
University Park 15
Jinan 14
Zhengzhou 14
Fremont 13
Montreal 13
Rio de Janeiro 13
Augusta 12
Belo Horizonte 12
Costa Mesa 12
Hải Dương 12
Paris 12
Stockholm 12
Baghdad 11
Da Nang 11
Jiaxing 11
Naples 11
Nuremberg 11
Chennai 10
Denver 10
Atlanta 9
Auburn Hills 9
Brasília 9
Hyderabad 9
Kent 9
Roubaix 9
Abidjan 8
Düsseldorf 8
Erbil 8
Haiphong 8
Johannesburg 8
Manchester 8
Totale 6.606
Salva come PNG Salva come JPEG
Nome #
Factors associated with mortality in bacteremic patients with hematologic malignancies. 374
Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy 357
Factors associated with mortality in bacteremic patients with haematologic malignancies 356
Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients 355
(1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: an observational study 313
Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy 310
(1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: An observational study 308
Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. 280
Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. 264
Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome 240
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy. 231
Pharmacokinetics of etravirine in HIV-infected patients concomitantly treated with rifampin for tuberculosis 230
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 224
Factors associated with mortality in bacteremic patients with hematologic malignancies. 218
Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system. 215
Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital 204
High-dose daptomycin for cardiac implantable electronic device-related infective endocarditis caused by staphylococcal small-colony variants 197
Carbapenemase-producing Klebsiella pneumoniae and hematologic malignancies 196
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy. 195
Safety and effectiveness of transvenous lead extraction in octogenarians 193
Predictive models for identification of hospitalized patients harboring KPC-producing Klebsiella pneumoniae 189
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy 184
Tuberculous spondylodiscitis: epidemiology, clinical features, treatment, and outcome 184
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 183
Characteristics of staphylococcus aureus bacteraemia and predictors of early and late mortality 183
Antimicrobial-resistant Gram-negative bacteria in febrile neutropenic patients with cancer: current epidemiology and clinical impact 182
Revised central nervous system neuropenetration-effectiveness score is associated with cognitive disorders in HIV-infected patients with controlled plasma viraemia 179
The effect of polymorphisms in candidate genes on the long-term risk of lipodystrophy and dyslipidemia in HIV-infected white patients starting antiretroviral therapy 177
Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010. 176
A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae 171
A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae 170
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy 165
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 164
Mortality in patients with early- or late-onset candidaemia 163
. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. 159
Multidrug-resistant Proteus mirabilis bloodstream infections: risk factors and outcomes 158
Virological control and metabolic improvement in HIV-infected, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy 157
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 156
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality. 154
Efficacy of Ceftazidime-avibactam Salvage Therapy in Patients with Infections Caused by KPC-producing Klebsiella pneumoniae 153
Evaluation of the practice of antifungal prophylaxis use in patients with newly diagnosed acute myeloid leukemia: results from the SEIFEM 2010-B registry 152
Carbapenemase-producingKlebsiella pneumoniaeand Hematologic Malignancies 152
Esthesioneuroblastoma in an HIV-1 Infected Patient: Case Report 151
Derivation and validation of a scoring system to identify patients with bacteremia and hematological malignancies at higher risk for mortality 149
Microbiologic and clinical characteristics of biofilm-forming Candida parapsilosis isolates associated with fungaemia and their impact on mortality 149
Derivation and Validation of a Scoring System to Identify Patients with Bacteremia and Hematological Malignancies at Higher Risk for Mortality 148
Incidence, risk factors, and predictors of outcome of candidemia. Survey in 2 Italian university hospitals. 147
Mortality in patients with early- or late-onset candidaemia 145
Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: A multinational pre-registered cohort study 140
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study 139
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study 138
Epidemiological and clinical features of pyogenic spondylodiscitis. 136
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study 136
Mortality in patients, with early-or late-onset candidaemia 135
Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study 135
Bloodstream infections caused by Escherichia coli in onco-haematological patients: Risk factors and mortality in an Italian prospective survey 134
Uncommon yeast infections in hematological patients: from diagnosis to treatment 133
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 131
Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study 126
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 125
Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria 119
Efficacy and durability of two- vs. three-drug integrase inhibitor-based regimens in virologically suppressed HIV-infected patients: Data from real-life ODOACRE cohort 119
Utility, acceptability and applicability of a nucleic acid amplification test in comparison with a syndromic approach in the management of sexually transmitted diseases at Mulago National Referral Hospital in Uganda (ASTRHA): Protocol for an open-label, randomised controlled trial 115
Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies 114
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Infections: A Retrospective Observational Multicenter Study 111
Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies 111
A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality 111
Enzyme-Linked Immunospot Assay as a Complementary Method to Assess and Monitor Cytomegalovirus Infection in Kidney Transplant Recipients on Pre-emptive Antiviral Therapy: A Single-Center Experience 110
Isavuconazole-Animal Data and Clinical Data 109
When Viruses Meet Fungi: Tackling the Enemies in Hematology 106
Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients 105
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 104
Therapeutic options for carbapenem-resistant Enterobacteriaceae infections 103
Bloodstream infections due to Gram-negative bacteria in patients with hematologic malignancies: updated epidemiology and risk factors for multidrug-resistant strains in an Italian perspective survey 101
Fluconazole use as an important risk factor in the emergence of fluconazole-resistant Candida glabrata fungemia 100
Mortality in patients with early- or late-onset candidaemia 86
Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia 82
An autochthonous case of cutaneous bacillary angiomatosis not related to major immunosuppression: An emerging or overlooked disease? 77
Detecting risk and predicting patient mortality in patients with extended-spectrum β-lactamase-producing Enterobacteriaceae bloodstream infections 77
Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital 76
Detecting risk and predicting patient mortality in patients with extended-spectrum β-lactamase-producing Enterobacteriaceae bloodstream infections 75
New advances in management and treatment of cardiac implantable electronic devices infections 69
COVID-19-associated pulmonary aspergillosis in intensive care unit: A real-life experience 66
Bloodstream infections caused by extended-spectrum-β-lactamase- producing Escherichia coli: Risk factors for inadequate initial antimicrobial therapy 53
Lopinavir/ritonavir and darunavir/cobicistat in hospitalized covid-19 patients: Findings from the multicenter italian corist study 9
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study 5
Evolution of in-hospital patient characteristics and predictors of death in the COVID-19 pandemic across four waves: are they moving targets with implications for patient care? 3
null 3
Omic insights into various ceftazidime-avibactam-resistant Klebsiella pneumoniae isolates from two southern Italian regions 3
Cefiderocol therapy among immunocompromised adult patients: a descriptive analysis from a prospective, multicentre cohort study 3
Spike-specific T-cell responses in patients with COVID-19 successfully treated with neutralizing monoclonal antibodies against SARS-CoV-2 2
Clinical phenotypes and outcomes in children with multisystem inflammatory syndrome across SARS-CoV-2 variant eras: a multinational study from the 4CE consortium 2
New advances in management and treatment of multidrug-resistant Klebsiella pneumoniae 1
RAAS inhibitors are not associated with mortality in COVID-19 patients: Findings from an observational multicenter study in Italy and a meta-analysis of 19 studies 1
Mortality in KPC-producing Klebsiella pneumoniae bloodstream infections: a changing landscape 1
Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study 1
Touching Base with Some Mediterranean Diseases of Interest from Paradigmatic Cases at the “Magna Graecia” University Unit of Infectious Diseases: A Didascalic Review 1
Sars-cov-2: Some aspects of molecular evolution, cellular pathogenesis, and immune system mechanism elusion 1
Prevalence of Antibiotic Resistance Over Time in a Third-Level University Hospital 1
Totale 13.804
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.036
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.036
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202113 0 0 0 0 0 0 0 0 0 0 0 13
2021/2022856 83 83 47 48 52 39 12 140 38 63 116 135
2022/20231.567 191 223 115 246 89 196 86 126 176 29 69 21
2023/2024649 39 198 13 26 19 91 48 23 9 25 81 77
2024/20251.371 50 35 109 30 171 51 41 56 213 99 280 236
2025/20263.906 568 97 209 442 759 182 658 197 195 263 179 157
Totale 13.804